The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk
Physiological Reports · 2025-04 · 13 (8)
DOI: 10.14814/phy2.70313 ↗At a glance
Journal article in Physiological Reports, 2025-04. Written by Cameron R Wiley and 9 co-authors. Institution: Department of Psychological Science, University of California, Irvine, Irvine, California, USA. Major MEDLINE topics: Heart Rate, Inflammation, Cardiovascular Diseases, Lipid Accumulation Product. Cited 12 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Mannheimer Institute für Public Health, Sozial- und Präventivmedizin.
Abstract (original language)
Deleterious adiposity (e.g., obesity) is considered an inflammatory condition that increases risk for cardiovascular diseases. Lower heart rate variability (HRV), an independent predictor of cardiovascular disease risk, is linked with higher levels of adiposity and inflammation. However, indices of adiposity vary in their strength of association with disease risk. Body mass index (BMI) is a modest predictor of disease, while the lipid accumulation product (LAP) better predicts disease risk. The current investigation used cross‐sectional and prospective designs to probe the differential associations between HRV and multiple measures of adiposity (e.g., LAP and BMI) and examine if inflammation (measured via C‐reactive protein; CRP) mediated these associations. Study 1 showed that HRV was more strongly linked with LAP relative to other adiposity measures and that this link was mediated by CRP. Study 2 replicated Study 1 results and showed that this association remained significant 4 years later. Our novel findings are consistent with studies suggesting LAP may be a superior measure of cardiovascular disease risk relative to other measures of adiposity. Importantly, the strong link between HRV and LAP was mediated by inflammation, highlighting the key role of the cholinergic anti‐inflammatory pathway in regulating obesity and associated health consequences.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Psychological Science, University of California, Irvine, Irvine, California, USA.
- Institute of Medical Psychology, Center for Psychosocial Medicine, University Hospital Heidelberg, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
- Department of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
- Mannheim Institute of Public Health, Social and Preventive Medicine, Mannheim Medical Faculty, Heidelberg University, Mannheim, Germany.
- BIOTEKNA Biomedical Technologies, Venice, Italy.
- Open Academy of Medicine, London, UK.
ORCID profiles: Cameron R Wiley, Julian F Thayer, DeWayne P Williams
Funding
- Mannheimer Institute für Public Health, Sozial- und Präventivmedizin
Cite
APA
Wiley, C. R., Pourmand, V., Stevens, S. K., Jarczok, M. N., Fischer, J. E., Boschiero, D., Poggiogalle, E., Koenig, J., Thayer, J. F., & Williams, D. P. (2025). The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk. Physiological Reports. https://doi.org/10.14814/phy2.70313
Vancouver
Wiley CR, Pourmand V, Stevens SK, Jarczok MN, Fischer JE, Boschiero D, et al. The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk. Physiological Reports. 2025. doi:10.14814/phy2.70313
BibTeX
@article{Wiley2025,
author = {Wiley, Cameron R and Pourmand, Vida and Stevens, Sarah K and Jarczok, Marc N and Fischer, Joachim E and Boschiero, Dario and Poggiogalle, Eleonora and Koenig, Julian and Thayer, Julian F and Williams, DeWayne P},
title = {The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70313}
}
EUVIMED